Literature DB >> 7020324

Glial fibrillary acidic protein in stromal cells of some capillary hemangioblastomas: significance and possible implications of an immunoperoxidase study.

J H Deck, L J Rubinstein.   

Abstract

Thirty-nine hemangioblastomas from 26 patients were studied by the immunoperoxidase method for GFA protein. Reactive gliosis in the form of trapped GFA protein-positive astrocytes or astrocytic cell processes penetrated the margins of all the neuraxial tumors and none of those occurring on nerve roots or in the tumor explants maintained in an organ culture system. Gliosis was especially prominent in tumors recurring after surgical excision or in patients with a long history of tumor. In six tumors, representing both the reticular and the cellular variants of hemangioblastoma, GFA protein-positive stromal cells were also found, chiefly in the periphery of the neoplasma: all these tumors were surrounded by dense reactive gliosis. Four hypotheses accounting for the presence of GFA protein-positive stromal cells are considered: (1) The tumors are astrocytomas. (2) The GFA protein-positive cells are not neoplastic but lipidized or altered reactive astrocytes. (3) The tumors are mixed and partly composed of neoplastic astrocytes. (4) The stromal cells are capable of taking up extracellular GFA protein derived from the adjacent reactive astrocytes. The last of these hypotheses is the most consistent with the collective evidence derived from the histological findings. It implies that the presence of GFA protein in the cytoplasm of a cell does not necessarily establish that the cell is glial. The possibility of uptake of GFA protein by non-glial cells must be considered if dense gliosis is present in the vicinity.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7020324     DOI: 10.1007/bf00687739

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  19 in total

1.  Angiomatosis retinae. An ultrastructural study and lipid analysis.

Authors:  F A Jakobiec; R L Font; F B Johnson
Journal:  Cancer       Date:  1976-11       Impact factor: 6.860

2.  The role of glial fibrillary acidic protein in the diagnosis of central nervous system tumors.

Authors:  J H Deck; L F Eng; J Bigbee; S M Woodcock
Journal:  Acta Neuropathol       Date:  1978-06-30       Impact factor: 17.088

3.  Sclerosing Hemangiomas of the Central Nervous System: Progressive Tissue Changes in Hemangioblastomas of the Brain and in SoCalled Angioblastic Menningiomas.

Authors:  O T Bailey; R Ford
Journal:  Am J Pathol       Date:  1942-01       Impact factor: 4.307

4.  Astroglial and axonal proteins in isolated brain filaments. I. Isolation of the glial fibrillary acidic protein and of an immunologically active cyanogen bromide peptide from brain filament preparations of bovine white matter.

Authors:  D Dahl; A Bignami
Journal:  Biochim Biophys Acta       Date:  1979-06-19

5.  Identification of glial fibrillary acidic protein by the immunoperoxidase method in human brain tumors.

Authors:  P E Duffy; L Graf; M M Rapport
Journal:  J Neuropathol Exp Neurol       Date:  1977-07       Impact factor: 3.685

6.  Cerebellar hemangioblastoma: histogenesis of stroma cells.

Authors:  J Kawamura; J H Garcia; Y Kamijyo
Journal:  Cancer       Date:  1973-06       Impact factor: 6.860

7.  Immunological study of the glial fibrillary acidic protein.

Authors:  C T Uyeda; L F Eng; A Bignami
Journal:  Brain Res       Date:  1972-02-11       Impact factor: 3.252

8.  Cerebellar hemangioblastoma: erythropoietic activity by radioiron assay.

Authors:  T G Hennessy; W E Stern; S E Herrick
Journal:  J Nucl Med       Date:  1967-08       Impact factor: 10.057

9.  Pathological and haematological aspects of posterior fossa haemangioblastomata.

Authors:  R Jeffreys
Journal:  J Neurol Neurosurg Psychiatry       Date:  1975-02       Impact factor: 10.154

Review 10.  Ultrastructure of cerebellar hemangioblastoma.

Authors:  A P Chaudhry; M Montes; G A Cohn
Journal:  Cancer       Date:  1978-10       Impact factor: 6.860

View more
  23 in total

1.  Supratentorial hemangioblastoma: clinical features, prognosis, and predictive value of location for von Hippel-Lindau disease.

Authors:  Steven A Mills; Michael C Oh; Martin J Rutkowski; Michael E Sughrue; Igor J Barani; Andrew T Parsa
Journal:  Neuro Oncol       Date:  2012-06-21       Impact factor: 12.300

2.  Histopathological features of recurrent pleomorphic xanthoastrocytomas: further corroboration of the glial nature of this neoplasm. A study of 3 cases.

Authors:  J J Kepes; L J Rubinstein; L Ansbacher; D J Schreiber
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

3.  Vascular growth factors and receptors in capillary hemangioblastomas and hemangiopericytomas.

Authors:  E Hatva; T Böhling; J Jääskeläinen; M G Persico; M Haltia; K Alitalo
Journal:  Am J Pathol       Date:  1996-03       Impact factor: 4.307

4.  Immunohistochemical study of fibronectin in hemangioblastomas and hemangiopericytomas.

Authors:  N Kochi; E Tani; K Kaba; S Natsume
Journal:  Acta Neuropathol       Date:  1984       Impact factor: 17.088

Review 5.  Central nervous system capillary haemangioblastoma: the pathologist's viewpoint.

Authors:  Mahmoud R Hussein
Journal:  Int J Exp Pathol       Date:  2007-10       Impact factor: 1.925

6.  Ultrastructure of cerebellar hemangioblastoma. Some new observations on the stromal cells.

Authors:  T Shimura; A Hirano; J F Llena
Journal:  Acta Neuropathol       Date:  1985       Impact factor: 17.088

7.  Distribution of endothelial and basement membrane markers in angiogenic tumors of the nervous system.

Authors:  T Böhling; A Paetau; P Ekblom; M Haltia
Journal:  Acta Neuropathol       Date:  1983       Impact factor: 17.088

8.  Use of immunohistochemical methods in the differential diagnosis between primary cerebellar haemangioblastoma and metastatic renal carcinoma.

Authors:  D R Gouldesbrough; J E Bell; A Gordon
Journal:  J Clin Pathol       Date:  1988-08       Impact factor: 3.411

9.  Immunohistochemical determination of protein kinase C expression and proliferative activity in human brain tumors.

Authors:  G Reifenberger; M Deckert; W Wechsler
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

10.  Non-glial specificities of immunocytochemistry for the glial fibrillary acidic protein (GFAP). Triple expression of GFAP, vimentin and cytokeratins in papillary meningioma and metastasizing renal carcinoma.

Authors:  H Budka
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.